[Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
The present study based on the indirect Clausen-test using NTA and PHA as antigens contributed to therapy control and possibly prognosis assessment rather than to immunological differential diagnosis.
D000328:Adult; D000941:Antigens / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D001921:Brain / Q000276:immunology*; D002464:Cell Migration Inhibition; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000276:immunology*; D009422:Nervous System Diseases / Q000175:diagnosis / Q000276:immunology; D010835:Phytohemagglutinins / Q000276:immunology
D000941:Antigens; D001324:Autoantigens; D007166:Immunosuppressive Agents; D009419:Nerve Tissue Proteins; D010835:Phytohemagglutinins
Erfahrungen mit dem indirekten Clausen-Test unter Verwendung von NTA als Antigen bei Multipler Sklerose und anderen neurologischen Erkrankungen.